Details
August 21, 2024
6:30PM - 8:00PM EST
OAPA Region 1 & 2 Dinner - CV Risk in Patients with CKD associated with T2D and CV Outcomes in Kerendia (finerenone) Clinical Trials
Presented by Jake Engelmeier, PharmD, RPh
Chagrin Valley Country Club
RSVP to presenter Jake Engelmeier, PharmD, RPh, at jacob.engelmeier@bayer.com.
Printer-Friendly Version